Hagop Youssoufian: I'm very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics

Hagop Youssoufian: I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics

Hagop Youssoufian, Youssoufian Consulting, LLC, posted on LinkedIn:

“I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics, which is aspiring to develop revolutionary CAR T therapies for a highly lethal form of thyroid cancer as well as lung cancer.”

View the article attached to the post.
Source: Hagop Youssoufian/LinkedIn

AffyImmune Therapeutics cancer CAR T therapies Clinical and Regulatory Advisory Board of AffyImmune Therapeutics Hagop Youssoufian highly lethal form cancer Lung cancer OncoDaily Oncology Revolutionary Therapies thyroid cancer